|Articles|February 1, 2010
- Pharmaceutical Executive-02-01-2010
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - February 2010
Shire’s Second Act
Advertisement
Articles in this issue
about 16 years ago
A Sturdy Frameworkabout 16 years ago
Vaccines and Valueabout 16 years ago
Tearing Up the Rule Bookabout 16 years ago
Assets for AdvantageNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
2
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
3
Teva Enters $900 Million Agreement to Acquire Emalex
4
Pharmaceutical Risks in the Strait of Hormuz
5